Agronomic portal Agronom.info
Categories
Language
Currency
My account
Corn

DKS 3609

Diseases
Fusarium
Country
USA
Registration Year
2022
Manufacturer
Monsanto
Offers: 1
Where to buy
Price range
4 838 - 4 838 UAH
Views
3
Reviews
0
Producer
Monsanto
Description DKS 3609
DKS 3609 is a high-yielding hybrid maize of medium-early maturity group with FAO index 260, intended for cultivation in areas with sufficient and unstable moisture. The crop is characterized by high adaptability and is suitable for various soil types, except sandy soils, as well as for different tillage technologies, including conventional, minimal, and No-Tillage. The recommended soil temperature at sowing is 8-9 °C, ensuring optimal conditions for germination and plant development.

The hybrid features a strong stem up to 230-240 cm tall and a robust root system, providing resistance to lodging and allowing for later harvest. Ear attachment height is 100-110 cm, with ears containing 14-16 rows and 34-37 kernels per row, totaling 570-650 kernels. The kernels are dent-flint type with high starch content, contributing to high yields. The recommended planting density varies depending on moisture: 70,000-75,000 plants per hectare under sufficient moisture and 65,000-70,000 under unstable conditions.

DKS 3609 exhibits high resistance to stalk and ear diseases, including fusarium, with resistance rating 9.0. The hybrid positively responds to elevated mineral nutrition levels, allowing yields up to 122 c/ha under basic moisture and up to 134 c/ha in production fields. Due to its characteristics and adaptability, DKS 3609 is a promising choice for farmers aiming for stable and high maize yields.
Specifications DKS 3609
Diseases
Fusarium
Fusarium
Hybrid Type
Hybrid
Use Direction
Grain
Ripening
Mid-early ripening
FAO
FAO 260
Recommended Density
65-70 thousand pcs/ha
70-75 thousand pcs/ha
Country
USA
Registration Year
2022
Catalog
Varieties
Field Crops
Manufacturer
Monsanto
Where to buy DKS 3609
Loading...
Reviews DKS 3609
0comments
Sort by:Popular first
No comments yet.